aXichem signs agreement with Res Pharma for marketing and distribution of aXivite in Italy
aXichem AB (publ), a developer of natural analogue industrial compounds, has entered into a marketing and distribution agreement with the Italian company Res Pharma and awarded them exclusivity in the Italian market for the aXivite product. “We are very happy to welcome Res Pharma in our distribution network. Due to their strong position in the Italian nutraceutical market, Res Pharma is the perfect partner for us and I am confident this is a very good start for aXivite in Italy.”, says Lucas Altepost, vice President and VP Sales